Ambien Claps Back at Roseanne, Walmart Offers a Big Perk and Dick's Sales Soar. 3 Things to Know Today.Stay in the know in 60 seconds.

ByStephen J. Bronner

  1. The makers of Ambien haverespondedto Roseanne Barr blaming the drug for her racist tweets, saying, "While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication."
  2. Walmart, the largest private industry employer, announced thatit will payto send its 1.5 million U.S. associates to college. Eligible employees can take online classes in business or supply-chain management at one of three non-profit universities.
  3. Dick's Sporting Goods made the controversial decision to restrict gun sales at its stores. But the companyposted higher quarterly profit and sales, thanks to increased purchases for other items.

Yesterday's video:Sheryl Sandberg Claps Back at Apple CEO Tim Cook's Facebook Disses. 3 Things to Know Today.

Stephen J. Bronner

Entrepreneur Staff

News Director

Stephen J. Bronner writes mostly about packaged foods. His weekly column isThe Digest. He is very much on top of his email.

Related Topics

Thought Leaders

5 Books Every Entrepreneur Should Read Before Starting a Business

A selection of books that helped me found and scale a startup from a $10,000 line of credit to a billion-dollar business

Business News

KFC Has Been Dethroned as No. 2 Chicken Chain in the U.S. — Here's Who Took Its Spot

A viral chicken sandwich led to an increase in market share.

Business News

Drew Barrymore's Writers Are Not Returning Amid Controversy, Despite End of Strike

The new season is slated to return to air on October 16.

Business News

'We Don't Sleep Well Anymore': Airbnb Host Grapples With 'Tenant From Hell' Who Refuses to Leave

An Airbnb guest rented a guesthouse for a long-term stay in 2021 but has since remained in the unit for over 540 days — without paying rent.

Business News

Judge Dismisses Lawsuit Accusing Wendy's and McDonald's of Size Exaggeration in Ads

The judge wondered if the plaintiff had even seen the advertisements in question.

Science & Technology

Elon Musk's Neuralink Seeks Volunteers. Is the Potential Help Worth It?

With the first round of human trials, regulatory challenges and ethical concerns are two important topics.